Decreased parvalbumin mRNA levels in cerebellar Purkinje cells in autism.
Autism brains have fewer calming Purkinje cells in the cerebellum, linking motor and mind-reading quirks to one spot.
01Research in Context
What this study did
Scientists looked at brain tissue from people with autism after death. They measured how much parvalbumin mRNA was in cerebellar Purkinje cells. Parvalbumin is a protein that helps fast brain cells stay calm.
What they found
The autism group had much lower parvalbumin gene activity in these cells. Lower levels mean the cerebellum has fewer working brakes. This adds the cerebellum to the list of brain areas with calming-cell problems.
How this fits with other research
Lanfranchi et al. (2021) extends this idea. They scanned living adults and saw shrinkage in the same cerebellar spot. People with autism and people with cerebellar disease both struggled with reading minds.
Matson et al. (1994) found a twist that looks like a clash but is not. Their eye-blink test showed autistic people learned the blink faster, not slower. The timing was off, though, which still points to a mis-tuned cerebellum.
Feldman et al. (1999) used PET scans and saw less cerebellar activity during sound tasks. The low activity lines up with the low parvalbumin found here.
Why it matters
You now have a second brain region to watch. If a client shows odd timing, balance, or rapid skill learning issues, the cerebellum may be part of the story. Share the Silvia paper with OTs or PTs who run coordination drills. It gives them a neural reason to keep practice short and precise.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add a five-minute bean-bag toss or balance beam to your session and note any over-shoot or timing errors.
02At a glance
03Original abstract
UNLABELLED: Recent neuropathology studies in human brains indicate that several areas of the prefrontal cortex have decreased numbers of parvalbumin interneurons or decreased parvalbumin expression in Autism Spectrum disorders (ASD) [Hashemi, Ariza, Rogers, Noctor, & Martinez-Cerdeno, 2017; Zikopoulos & Barbas, ]. These data suggest that a deficit in parvalbumin may be a key neuropathology of ASD and contribute to altered GABAergic inhibition. However, it is unclear if a deficit in parvalbumin is a phenomenon that occurs in regions other than the cerebral cortex. The cerebellum is a major region where neuropathology was first detected in ASD over three decades ago [Bauman & Kemper, ]. In view of the documented association between parvalbumin-expressing neurons and autism, the objective of the present study was to determine if parvalbumin gene expression is also altered in Purkinje neurons of the cerebellum. Radioisotopic in situ hybridization histochemistry was used on human tissue sections from control and ASD brains in order to detect and measure parvalbumin mRNA levels at the single cell level in Purkinje cells of Crus II of the lateral cerebellar hemispheres. Results indicate that parvalbumin mRNA levels are significantly lower in Purkinje cells in ASD compared to control brains. This decrease was not influenced by post-mortem interval or age at death. This result indicates that decreased parvalbumin expression is a more widespread feature of ASD. We discuss how this decrease may be implicated in altered cerebellar output to the cerebral cortex and in key ASD symptoms. Autism Res 2017, 10: 1787-1796. © 2017 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: The cerebellum of the brain controls movement and cognition, including memory and language. This study investigated mechanisms of cerebellar function in Autism. Our hypothesis is that parvalbumin, a molecule that controls and coordinate many cellular brain functions, contributes to the excitatory/inhibitory imbalance in Autism. We report that parvalbumin expression is depressed in Purkinje cells of the cerebellum in autism. This finding contributes to elucidate the cellular and molecular underpinings of autism and should provide a direction for future therapies.
Autism research : official journal of the International Society for Autism Research, 2017 · doi:10.1002/aur.1835